• Santaris purchase takes Roche into new class of medicines

News & Views

Santaris purchase takes Roche into new class of medicines

Sep 05 2014

Roche has announced its agreement to acquire Santaris Pharma, a privately held biopharmaceutical company based near Copenhagen, Denmark. Santaris Pharma has pioneered its proprietary Locked Nucleic Acid (LNA) platform that has contributed to an emerging era of RNA-targeting therapeutics. This new class of medicines has the potential to address difficult to treat diseases in a range of therapeutic areas.

 “Today there are many disease targets that are very challenging or even impossible to reach with small molecules or antibodies,” said John C. Reed, Head of Roche Pharma Research and Early Development.

“We believe the LNA platform provides the means to efficiently discover and develop an important new class of medicines that may address the significant needs of patients across multiple therapeutic areas.” 

“Roche and Santaris Pharma have complementary capabilities that will help us realise breakthrough medicines,” said  J. Donald deBethizy, President and CEO of Santaris Pharma. “The acquisition combines Santaris Pharma’s next-generation antisense technology and LNA expertise with Roche’s deep experience in disease biology, chemistry, drug safety, drug formulation, delivery, and development.”

The acquisition, which is subject to customary closing conditions, was expected to close in August 2014.

Roche plans to maintain Santaris Pharma’s operations in Denmark, where the existing site will be renamed Roche Innovation Center Copenhagen. Under the terms of the agreement, Roche will make an upfront cash payment of USD 250 million to Santaris Pharma shareholders and make additional contingent payments of up to USD 200 million based on the achievement of certain predetermined milestones.


Digital Edition

International Labmate 49.6 - Sept 2024

September 2024

Chromatography Articles - HPLC gradient validation using non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - From R&D to QC, making NMR accessible for everyone: Putting NMR...

View all digital editions

Events

ISSS 2024

Sep 22 2024 Messina, Italy

19th Confocal Raman Imaging Symposium

Sep 23 2024 Ulm, Germany

Control-Tech

Sep 24 2024 Kielce, Poland

WoTS - World of Technology and Science

Sep 24 2024 Utrecht, Holland

Cleanzone 2024

Sep 25 2024 Frankfurt am Main, Germany

View all events